Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling
<p>Abstract</p> <p>Background</p> <p>Only a minority of patients with advanced non-small cell lung cancer (NSCLC) benefit from chemotherapy. Serum peptide profiling of NSCLC patients was performed to investigate patterns associated with treatment outcome.</p> <...
Main Authors: | Giaccone Giuseppe, Knol Jaco C, Pham Thang V, Voortman Johannes, Jimenez Connie R |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-09-01
|
Series: | Proteome Science |
Online Access: | http://www.proteomesci.com/content/7/1/34 |
Similar Items
-
FEATURES OF BACILLUS ANTHRACIS IDENTIFICATION BY MALDI-TOF MS
by: E. A. Koteneva, et al.
Published: (2018-12-01) -
Application Of The Maldi-Tof Ms Technique For Identification Of Dermatophytes
by: Gnat Sebastian, et al.
Published: (2020-01-01) -
MALDI-TOF MS Analysis of Serum Peptidome Patterns in Cervical Cancer
by: Phetploy Rungkamoltip, et al.
Published: (2023-08-01) -
MALDI-TOF-MS for rapid screening analysis of M-protein in serum
by: Jie Li, et al.
Published: (2022-12-01) -
Novel Biomarkers of Mastitis in Goat Milk Revealed by MALDI-TOF-MS-Based Peptide Profiling
by: Monica Matuozzo, et al.
Published: (2020-07-01)